What’s Next For Moderna Post-Covid-19: CEO Stéphane Bancel Details mRNA Pipeline One of the world’s first mRNA vaccines made Bancel a billionaire—and now the biotech CEO discusses his plans to use the mRNA breakthrough for cancer, genetic disorders, and even a better flu vaccine.